Site-specific Tau Phosphorylation to Treat and Understand Alzheimer’s Disease [ 2018 - 2020 ]

Research Grant

[Cite as]

Researchers: Dr Yazi Ke

Brief description Alzheimer’s disease (AD) is the most common form of dementia. Unfortunately, current therapies are ineffective. Our laboratory has made an important contribution to understanding the events that lead to brain cell malfunction in AD. I recently found a novel concept that changes the view of AD completely. In the next 3 years, I aim to develop therapeutic tools based on this novel concept and find out more about how it can protect brains from AD.

Funding Amount $AUD 957,116.64

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]